Latest Allergan Stories
Label updates include addition of two thumb flexor muscles and increased maximum cumulative dose DUBLIN, April 20, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), which recently completed the
Verdict in Prior Botox Suit Alerts Family BURLINGTON, Vt., April 10, 2015 /PRNewswire/ -- Parents of Melinda Ann "Mandy" Fortuna of Shelburne, Vermont filed suit yesterday against
LONDON, April 9, 2015 /PRNewswire/ -- Cosmetic implants are the devices used to place inside or over the body part(s) in order to modify the beauty and physical appearance of an individual.
LONDON, March 27, 2015 /PRNewswire/ -- Report Details New study shows you commercial prospects for leading ophthalmic drug companies What does
TORONTO, March 26, 2015 /CNW/ - Mediaplanet announces the distribution of its cross-platform campaign "Vision Health", raising awareness about various vision health issues: how to prevent them;
SANTA ANA, Calif., March 24, 2015 /PRNewswire/ -- Ingram Micro Inc. (NYSE: IM) today announced the appointment of Scott
DUBLIN, March 17, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that two former members of the Allergan Board of Directors - Michael R.
- Combination Creates One of the Fastest Growing, Most Dynamic Pharmaceutical Companies in Global Healthcare - DUBLIN, March 17, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT)
New research report “Global Cosmetic Surgery and Service Market Report 2015-2019” elaborated by Kelly Scientific Publications is available at MarketPublishers.com.
DUBLIN and IRVINE, Calif., March 16, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) ("Actavis") and Allergan, Inc.
- Growing in low tufty patches.